Skip to main content

Peer Review reports

From: Study Protocol for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a pragmatic, registry-based, multi-center, double-blind, randomized controlled trial evaluating the effect of intravenous fluid therapy with Plasma-Lyte 148 versus 0.9% saline on delayed graft function in deceased donor kidney transplantation

Original Submission
3 Apr 2020 Submitted Original manuscript
21 Apr 2020 Reviewed Reviewer Report - Kirsty Loudon
22 Apr 2020 Author responded Author comments - Michael Collins
Resubmission - Version 2
22 Apr 2020 Submitted Manuscript version 2
28 Apr 2020 Editorially accepted
25 May 2020 Article published 10.1186/s13063-020-04359-2

You can find further information about peer review here.

Back to article page